Full-Time

Clinical Training Manager

Updated on 8/1/2026

Neuronetics

Neuronetics

51-200 employees

Non-invasive TMS device for depression

No salary listed

No H1B Sponsorship

Houston, TX, USA + 3 more

More locations: Detroit, MI, USA | Cleveland, OH, USA | St. Louis, MO, USA

Remote

Remote within the United States, with up to 80% nationwide travel.

Category
Training

Get referred to Neuronetics

See people who can refer or advise you

Requirements
  • At least 3 years of clinical experience in a healthcare setting.
  • At least 2 years of clinical training, education, or staff development experience.
  • At least 2 years of medical device experience.
  • Ability to travel up to 80% nationally.
  • Authorization to work for any employer in the United States is required; employment visa or work-authorization sponsorship is not available.
Responsibilities
  • Deliver in-person onboarding and clinical training programs at centers nationwide.
  • Facilitate clinician certification and competency assessments.
  • Train staff on NeuroStar transcranial magnetic stimulation therapy, patient care protocols, and workflow best practices.
  • Coach and develop clinicians through ongoing feedback and performance support.
  • Track training records, certifications, and learning management system data integrity.
  • Partner with Operations, Regional Leadership, and Clinical Leadership to drive training excellence.
  • Support the development and enhancement of training materials, standard operating procedures, and educational programs.
Desired Qualifications
  • Bachelor's degree in Nursing, Psychology, or a related healthcare field.
  • Experience in behavioral health, mental health, neuromodulation therapies, or medical device training.
  • Familiarity with NeuroStar transcranial magnetic stimulation and multi-site clinical operations.

Neuronetics develops non-invasive brain-stimulation devices for psychiatric conditions, led by the NeuroStar Advanced Therapy system that uses transcranial magnetic stimulation to modulate mood-related brain activity. The NeuroStar device delivers targeted magnetic pulses in outpatient sessions that require no anesthesia and can last from a few minutes to about 30 minutes. The company differentiates itself with FDA clearances for OCD and adolescent MDD, a dual revenue model from device sales/leases and its own network of treatment centers, plus clinician-support programs. Its goal is to broaden neuromodulation use, grow its installed base and approvals, and scale device sales and clinic operations to treat more patients.

Company Size

51-200

Company Stage

IPO

Headquarters

Malvern, Iowa

Founded

2003

Get referred to Neuronetics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Shipments rose 10% in Q1 2026, showing continued commercial demand.
  • Greenbrook revenue grew 15% from SPRAVATO and buy-and-bill expansion.
  • Expanded commercial models and workflow optimization can widen adoption and utilization.

What critics are saying

  • Gross margin fell after Greenbrook integration, pressuring profitability.
  • Neuronetics has reported losses and negative operating cash flow for years.
  • Cash declined to $19.0 million, while 2026 cash burn remains negative.

What makes Neuronetics unique

  • NeuroStar is FDA-cleared for MDD, OCD, and adolescents 15-21.
  • ANT Neuro neuronavigation adds real-time 3D guidance to TMS delivery.
  • Greenbrook ownership gives Neuronetics both device sales and clinic revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Life Insurance

Disability Insurance

Short Term Disability

Long Term Disability

401(k) Company Match

Remote Work Options

Growth & Insights

Headcount

6 month growth

1%

1 year growth

4%

2 year growth

0%